Detalles de la búsqueda
1.
Indirect treatment comparison of oral versus injectable azacitidine as maintenance therapy for acute myeloid leukemia.
Future Oncol
; 2022 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36507931
2.
The cost-effectiveness of initial treatment of multiple myeloma in the U.S. with bortezomib plus melphalan and prednisone versus thalidomide plus melphalan and prednisone or lenalidomide plus melphalan and prednisone with continuous lenalidomide maintenance treatment.
Oncologist
; 18(1): 27-36, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23299777
3.
Efficacy and Safety of Advanced Therapies for Moderately to Severely Active Ulcerative Colitis at Induction and Maintenance: An Indirect Treatment Comparison Using Bayesian Network Meta-analysis.
Crohns Colitis 360
; 5(2): otad009, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36998249
4.
Cost-Effectiveness of Chimeric Antigen Receptor T Cell Therapy in Patients with Relapsed or Refractory Large B Cell Lymphoma: No Impact of Site of Care.
Adv Ther
; 39(8): 3560-3577, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35689726
5.
Treatment of transfusional iron overload in patients with myelodysplastic syndrome or severe anemia: data from multicenter clinical practices.
Transfusion
; 50(1): 190-9, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19719471
6.
Angiogenesis inhibitor therapies for metastatic renal cell carcinoma: effectiveness, safety and treatment patterns in clinical practice-based on medical chart review.
BJU Int
; 105(9): 1247-54, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19863525
7.
Cost utility of adalimumab versus infliximab maintenance therapies in the United States for moderately to severely active Crohn's disease.
Pharmacoeconomics
; 27(7): 609-21, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19663531
8.
Cost-effectiveness model for a hypothetical monotherapy vs standard of care in adult patients with treatment-resistant depression.
Clinicoecon Outcomes Res
; 11: 257-270, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30936731
9.
Cost-effectiveness of elagolix versus leuprolide acetate for treating moderate-to-severe endometriosis pain in the USA.
J Comp Eff Res
; 8(5): 337-355, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30724096
10.
Treatment of peripheral neuropathic pain: a simulation model.
Eur J Pain
; 10(3): 279-85, 2006 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-15979360
11.
Cost-effectiveness of rivaroxaban compared with enoxaparin plus a vitamin K antagonist for the treatment of venous thromboembolism.
J Med Econ
; 17(1): 52-64, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24156243
12.
Safety and treatment patterns of angiogenesis inhibitors in patients with metastatic renal cell carcinoma: evidence from US community oncology clinics.
Med Oncol
; 29(2): 786-94, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21479699
13.
Lifetime costs to Medicare of providing care to patients with chronic lymphocytic leukemia.
Leuk Lymphoma
; 53(6): 1146-54, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22111902
14.
Risk-benefit analysis of adalimumab versus traditional non-biologic therapies for patients with Crohn's disease.
Inflamm Bowel Dis
; 17(1): 127-40, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20848523
15.
Importance of transparency in assessing the feasibility of modeling rare disease.
Med Decis Making
; 35(2): 143-4, 2015 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-25505051
Resultados
1 -
15
de 15
1
Próxima >
>>